The cytokine milieu at the time of antigen presentation drives T cell polarization.
Persistent antigen presentation drove gp100-specific pmel-1 T cell accumulation at the injection site where these T cells largely became hyporesponsive and underwent apoptosis through a mechanism involving interferon-g and Fas ligand.
Sharply higher prices for tickets across the board, but especially for 3-D presentations, drove the increase.
Because stage at presentation drives mortality in lung cancer, it is critical to understand factors that influence screening behavior in lung cancer screening in order to intervene.
Our studies provide in vitro and in vivo evidence that B cell antigen presentation drives Th2 cytokine production during allergic lung disease.
At a session that emphasised "seeking community" with people of other faiths, cultures and ideologies, the presentations were driven by, as the former director of the WCC sub-unit Dialogue with People of Living Faiths and Ideologies (DFI) – S. J. Samartha – put it: "fear of losing the 'uniqueness' of Christ, fear of weakening the sense of 'mission', and the persistent fear of 'syncretism'".
As a result of EBV infection, persistent presentation of viral antigens could impose pressure on the T-cell repertoire, contributing with self-antigen presentation to drive expansion of an activated memory population, which further acquires inflammation-associated TCR signalling defects.
His presentation could drive an imagemaker mad.
This presentation may drive aberrant memory T cell responses, promoting B cell activation and immunoglobulin class switching.
This is not a ranking on merit, but simply an order of presentation to drive the mate allocation part: The first ranked male mating is the single mating of male 3 and it is thus allocated to the first available female mating (the one nearest to the left) - the only mating of female 1.
The type of pack presentation selected is driven by the quality target product profile (QTPP) that is designed around the physicochemical properties of the drug substance and the desired drug product suitability for the target population.
